Eurazeo Capital to Acquire DORC From Montagu

Source: Eurazeo Capital

Eurazeo Capital will acquire ophthalmic instrument maker DORC (Dutch Ophthalmic Research Center) from Montagu Private Equity for about EUR300 million.

Established in 1983 and headquartered in the Netherlands, DORC is a specialist in vitreoretinal surgery, and designs, manufactures, and distributes ophthalmic surgery equipment, consumables, and instruments.

DORC is a global company with a presence in 80 countries and has more than 500 employees worldwide.
 “The acquisition of DORC fits perfectly with our investment strategy to support growing businesses with a strong international development potential as they scale up,” Marc Frappier, Managing Partner, Head of Eurazeo Capital, said in a news release. “Wi76dely recognized as innovative and best in class by surgeons across the world, the company delivers remarkable financial performance. We expect to leverage our international network to accelerate DORC’s growth.”

Additional financial information will be disclosed at the closing of the transaction.



Related Content